Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-009504
Filing Date
2023-03-23
Accepted
2023-03-23 16:19:28
Documents
5
Effectiveness Date
2023-03-23

Document Format Files

Seq Description Document Type Size
1 S-8 cyt-form_s-8-2023.htm S-8 150503
2 EX-5.1 cyt-ex5_1.htm EX-5 14087
3 EX-23.1 cyt-ex23_1.htm EX-23 4836
4 EX-FILING FEES cyt-exfiling_fees.htm EX-FILING FEES 37301
5 GRAPHIC img21563576_0.jpg GRAPHIC 8165
  Complete submission text file 0000950170-23-009504.txt   219152
Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Filer) CIK: 0001662244 (see all company filings)

EIN.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270787 | Film No.: 23756484
SIC: 2834 Pharmaceutical Preparations